Key result
Targeting platelet mitochondrial pathways shows preclinical promise for reducing thrombotic complications in metabolic disorders.
Why the study?
Platelet mitochondrial dysfunction is linked to oxidative stress, a hallmark of metabolic disorders like dyslipidemia and diabetes that confer higher risks of thrombotic complications.
Does targeting platelet mitochondrial pathways reduce thrombotic complications in metabolic disorders?
Does targeting platelet mitochondrial pathways reduce thrombotic complications in metabolic disorders?
Targeting platelet mitochondria represents a promising preclinical strategy to reduce thrombotic complications in metabolic disorders without significantly impairing hemostasis.
PURPOSE OF REVIEW: Platelet mitochondrial dysfunction is both caused by, as well as a source of oxidative stress. Oxidative stress is a key hallmark of metabolic disorders such as dyslipidemia and diabetes, which are known to have higher risks for thrombotic complications. RECENT FINDINGS: Increasing evidence supports a critical role for platelet mitochondria beyond energy production and apoptosis. Mitochondria are key regulators of reactive oxygen species and procoagulant platelets, which both contribute to pathological thrombosis. Studies targeting platelet mitochondrial pathways have reported promising results suggesting antithrombotic effects with limited impact on hemostasis in animal models. SUMMARY: Targeting platelet mitochondria holds promise for the reduction of thrombotic complications in patients with metabolic disorders. Future studies should aim at validating these preclinical findings and translate them to the clinic.
No takes yet. Share an insight, caveat, or question.
Ajanel et al. (2023) conducted a review in Metabolic disorders and thrombotic complications. Targeting platelet mitochondrial pathways was evaluated. Targeting platelet mitochondrial pathways holds promise for reducing thrombotic complications in patients with metabolic disorders, based on preclinical studies showing antithrombotic effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: